We can't find the internet
Attempting to reconnect
Something went wrong
Hang in there while we get back on track
£88.19
Springer Targeted Interference with Signal Transduction Events: 172 (Recent Results in Cancer Research, 172)
Price data last checked 47 day(s) ago - refreshing...
We'll watch every seller, every day. One email when your price arrives.
This is the most expensive it has ever been. Walk away.
£88 today · previous high £88 · all-time low £88
NEW HERE?
Amazon shows you one price. We show you all of them.
Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.
WHAT'S ON THIS PAGE
when this has been cheap or pricey
where the price is heading next
all-time high & low, recent range
name your number, we'll email you
Price History & Forecast
Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.
Last 44 days · 44 data points (no recent data)
Price Distribution
Price distribution over 44 days • 1 price levels
Price Analysis
Most common price: £88 (44 days, 100.0%)
Price range: £88 - £88
Price levels: 1 different prices over 44 days
Description
Product Specifications
- Brand
- Springer
- Format
- paperback
- ASIN
- 3642068340
- Domain
- Amazon UK
- Release Date
- 18 November 2010
- Listed Since
- 01 October 2010
Barcode
No barcode data available
Similar Products You Might Like
Drug Targets in Cellular Processes of Cancer: From Nonclinical to Preclinical Models
Springer
Cell Signaling & Molecular Targets in Cancer
Springer
Cancer Drug Discovery: Science and History
Springer
Unravelling Cancer Signaling Pathways: A Multidisciplinary Approach
Springer
Resistance to Immunotoxins in Cancer Therapy: 6 (Resistance to Targeted Anti-Cancer Therapeutics, 6)
Springer
Drugs for HER-2-positive Breast Cancer (Milestones in Drug Therapy)
Springer
Drugs for HER-2-positive Breast Cancer (Milestones in Drug Therapy)
Springer
Molecular Oncology: Underlying Mechanisms and Translational Advancements
Springer
Nuclear Signaling Pathways and Targeting Transcription in Cancer (Cancer Drug Discovery and Development)
Humana
Resistance to Tyrosine Kinase Inhibitors (Resistance to Targeted Anti-Cancer Therapeutics)
Springer
Resistance to Tyrosine Kinase Inhibitors (Resistance to Targeted Anti-Cancer Therapeutics)
Springer
Cell Signaling & Molecular Targets in Cancer
Springer
Targeting the Wnt Pathway in Cancer
Springer
Pharmaceutical Perspectives of Cancer Therapeutics
Springer
Cancer Chemotherapy: Concepts, Clinical Investigations and Therapeutic Advances: 42 (Cancer Treatment and Research, 42)
Springer
Cancer Genetics and Therapeutics: Focus on Phytochemicals
Springer
Nutraceuticals and Cancer
Springer
Resistance to Targeted Therapies in Breast Cancer: 16 (Resistance to Targeted Anti-Cancer Therapeutics, 16)
Springer
Molecular Targeting in Oncology (Cancer Drug Discovery and Development)
Humana
Gene-Based Therapies for Cancer (Current Cancer Research)
Springer
Insulin-like Growth Factors and Cancer: From Basic Biology to Therapeutics (Cancer Drug Discovery and Development)
Humana
Molecular Targeted Therapy of Lung Cancer
Springer
Gene Regulation and Therapeutics for Cancer
CRC Press
New Approaches in Cancer Pharmacology: Drug Design and Development: Vol. II: 2 (ESO Monographs)
Springer